Order Article Reprints

Rabaan AA, Bakhrebah MA, Mohapatra RK, Farahat RA, Dhawan M, Alwarthan S, Aljeldah M, Al Shammari BR, Al-Najjar AH, Alhusayyen MA, et al. Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects. Pathogens. 2023; 12(1):39. https://doi.org/10.3390/pathogens12010039

Rabaan, Ali A., Muhammed A. Bakhrebah, Ranjan K. Mohapatra, Ramadan Abdelmoez Farahat, Manish Dhawan, Sara Alwarthan, Mohammed Aljeldah, Basim R. Al Shammari, Amal H. Al-Najjar, Mona A. Alhusayyen, and et al. 2023. "Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects" Pathogens 12, no. 1: 39. https://doi.org/10.3390/pathogens12010039

Rabaan, A. A., Bakhrebah, M. A., Mohapatra, R. K., Farahat, R. A., Dhawan, M., Alwarthan, S., Aljeldah, M., Al Shammari, B. R., Al-Najjar, A. H., Alhusayyen, M. A., Al-Absi, G. H., Aldawood, Y., Alsaleh, A. A., Alshamrani, S. A., Almuthree, S. A., Alawfi, A., Alshengeti, A., Alwashmi, A. S. S., Hajissa, K., & Nassar, M. S. (2023). Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects. Pathogens, 12(1), 39. https://doi.org/10.3390/pathogens12010039